RxDoctor Payments Data

Reginald Williams, MD

Family Medicine · Gold Beach, ORNPI 1225014632

Payments from drug & device makers

$1,223in general payments, 2019–2025

Across 68 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$176
  • Novartis$156
  • Sanofi-aventis U.S. LLC$131
  • Lilly USA, LLC$126
  • AstraZeneca$120
  • Exact Sciences$98
  • plus $417 from 11 others

What the payments were for

  • Food & beverage$1,223100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,223 in reported general payments places this provider in the 85th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$67,108
Medicare patients
243
Services billed
1,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban136$153,104
JardianceEmpagliflozin112$128,918
EliquisApixaban122$124,681
OzempicSemaglutide44$43,365
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$30,723
FarxigaDapagliflozin Propanediol26$27,828
TrulicityDulaglutide16$15,118
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$13,927
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$11,116
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$8,436
Rosuvastatin Calcium393$7,706
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$7,452
Metoprolol Succinate312$6,426
Lisinopril432$4,304
ShingrixVaricella-Zoster Ge/As01b/Pf18$4,041

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$176$153,104136 claims
Boehringer IngelheimJardiance$14$128,918112 claims
PfizerEliquis$42$124,681122 claims
Novo NordiskOzempic$61$43,36544 claims
AstraZenecaFarxiga, Breztri Aerosphere$120$41,75543 claims
GSKTrelegy Ellipta, Shingrix$69$34,76540 claims
Lilly USA, LLCTrulicity$126$15,11816 claims
AbbVieSynthroid$65$1,94438 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Gold Beach

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →